Multisite interactions of receptors and G proteins: enhanced potency of dimeric receptor peptides in modifying G protein function

SM Wade, HM Dalman, SZ Yang and RR Neubig

Department of Pharmacology, University of Michigan, Ann Arbor 48109- 0626.

Synthetic peptides that activate or inhibit G proteins reveal structural determinants of receptor-G protein interactions and show promise as potential therapeutic agents. A cysteine-containing peptide from the carboxyl-terminal part of the third cytoplasmic loop of the alpha 2-adrenergic receptor (peptide Q) uncouples alpha 2-adrenergic receptors from Gi. Peptide Q readily forms disulfide-linked dimers (Qdimer), as detected by high performance liquid chromatography and mass spectrometry. Qdimer is > 100-fold more potent than monomeric Q peptide in inhibiting p-[125I] iodoclonidine binding to the human alpha 2a-adrenergic receptor in platelet membranes and transfected Chinese hamster ovary cells. In addition, Qdimer is 10-20 times more potent than monomeric Q peptide in inhibiting alpha 2 agonist-stimulated GTPase in cell membranes and in directly stimulating G(o)/Gi GTPase in lipid vesicles. The effect of Qdimer is reversible and not mimicked by cystine. Formylation of both tryptophans greatly reduces the potency of the dimer but a single formyl group is well tolerated, indicating an asymmetric interaction of the dimer with Gi in membranes. A mixed dimer of peptides from the amino- and carboxyl-terminal ends of the third cytoplasmic loop of the alpha 2-adrenergic receptor is most potent in all measures of G protein interactions, suggesting that the dimer of Q peptides mimics multiple intracellular portions of the alpha 2- adrenergic receptor with the G protein. These data confirm the importance of multiple receptor regions in G protein activation and suggest a strategy for examining the role of physically separated regions in protein-protein interactions.

Volume 45, Issue 6, pp. 1191-1197, 06/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				S. Shacham, M. N. Cheifetz, M. Fridkin, A. J. Pawson, R. P. Millar, and Z. Naor Identification of Ser153 in ICL2 of the Gonadotropin-releasing Hormone (GnRH) Receptor as a Phosphorylation-independent Site for Inhibition of Gq Coupling J. Biol. Chem., August 12, 2005; 280(32): 28981 - 28988. [Abstract] [Full Text] [PDF]

				C. S. Pao and J. L. Benovic Structure/Function Analysis of {alpha}2A-Adrenergic Receptor Interaction with G Protein-coupledReceptor Kinase 2 J. Biol. Chem., March 25, 2005; 280(12): 11052 - 11058. [Abstract] [Full Text] [PDF]

				O. Madsen, D. Willemsen, B. M. Ursing, U. Arnason, and W. W. de Jong Molecular Evolution of the Mammalian Alpha 2B Adrenergic Receptor Mol. Biol. Evol., December 1, 2002; 19(12): 2150 - 2160. [Abstract] [Full Text] [PDF]

				C. Saunders and L. E. Limbird Microtubule-Dependent Regulation of alpha 2B Adrenergic Receptors in Polarized MDCKII Cells Requires the Third Intracellular Loop but Not G Protein Coupling Mol. Pharmacol., January 1, 2000; 57(1): 44 - 52. [Abstract] [Full Text]

				A. N. Abell, D. J. McCormick, and D. L. Segaloff Certain Activating Mutations within Helix 6 of the Human Luteinizing Hormone Receptor May Be Explained by Alterations That Allow Transmembrane Regions to Activate Gs Mol. Endocrinol., December 1, 1998; 12(12): 1857 - 1869. [Abstract] [Full Text]

				W. Y. Go, E. L. Holicky, E. M. Hadac, R. V. Rao, and L. J. Miller Identification of a domain in the carboxy terminus of CCK receptor that affects its intracellular trafficking Am J Physiol Gastrointest Liver Physiol, July 1, 1998; 275(1): G56 - G62. [Abstract] [Full Text] [PDF]

				A. C. Howlett, C. Song, B. A. Berglund, G. H. Wilken, and J. J. Pigg Characterization of CB1 Cannabinoid Receptors Using Receptor Peptide Fragments and Site-Directed Antibodies Mol. Pharmacol., March 1, 1998; 53(3): 504 - 510. [Abstract] [Full Text]

				D. Ghanekar, E. M. Hadac, E. L. Holicky, and L. J. Miller Differences in Partial Agonist Action at Cholecystokinin Receptors of Mouse and Rat Are Dependent on Parameters Extrinsic to Receptor Structure: Molecular Cloning, Expression and Functional Characterization of the Mouse Type A Cholecystokinin Receptor J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1206 - 1212. [Abstract] [Full Text]

				J. M. Taylor, G. G. Jacob-Mosier, R. G. Lawton, M. VanDort, and R. R. Neubig Receptor and Membrane Interaction Sites on Gbeta J. Biol. Chem., February 16, 1996; 271(7): 3336 - 3339. [Abstract] [Full Text] [PDF]

				J. G. Richman, A. E. Brady, Q. Wang, J. L. Hensel, R. J. Colbran, and L. E. Limbird Agonist-regulated Interaction between alpha 2-Adrenergic Receptors and Spinophilin J. Biol. Chem., April 27, 2001; 276(18): 15003 - 15008. [Abstract] [Full Text] [PDF]